aspirin and carboprostacyclin

aspirin has been researched along with carboprostacyclin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ailhaud, G; Gaillard, D; NĂ©grel, R1
Das, UN1
Dercho, RA; Di Francesco, A; Di Francesco, L; Dovizio, M; Evangelista, V; Pandolfi, A; Patrignani, P; Piccoli, A; Salvatore, T; Seta, F; Totani, L1

Reviews

1 review(s) available for aspirin and carboprostacyclin

ArticleYear
Atherosclerosis and prostaglandins.
    International journal of tissue reactions, 1982, Volume: 4, Issue:2

    Topics: Alprostadil; Arteriosclerosis; Aspirin; Blood Vessels; Cell Membrane Permeability; Cell Survival; Cholesterol; Endothelium; Epoprostenol; Humans; Platelet Adhesiveness; Prostaglandins; Prostaglandins E; Thromboxane A2

1982

Other Studies

2 other study(ies) available for aspirin and carboprostacyclin

ArticleYear
Prostacyclin as a potent effector of adipose-cell differentiation.
    The Biochemical journal, 1989, Jan-15, Volume: 257, Issue:2

    Topics: Adipose Tissue; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Cell Differentiation; Cell Line; Cyclic AMP; Epoprostenol; Humans; Indomethacin; Mice; Mitosis; Prostaglandins F; Prostaglandins, Synthetic; Rats

1989
Induction of prostacyclin by steady laminar shear stress suppresses tumor necrosis factor-alpha biosynthesis via heme oxygenase-1 in human endothelial cells.
    Circulation research, 2009, Feb-27, Volume: 104, Issue:4

    Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Atherosclerosis; Benzofurans; Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Down-Regulation; Endothelial Cells; Epoprostenol; Heme Oxygenase-1; Humans; Inflammation; Nitrobenzenes; Perfusion; Propionates; Prostaglandin D2; Receptors, Epoprostenol; Receptors, Prostaglandin; Stress, Mechanical; Sulfonamides; Tumor Necrosis Factor-alpha; Up-Regulation

2009